Europe's medicines watchdog on Friday rejected a request to market a new Alzheimer's disease treatment, saying the risks of the medicine's side effects, including potential brain bleeding, outweighed the benefits. Watch in for more details!

European medicines watchdog rejects new Alzheimer's drug

european-medicines-watchdog

European Medicines Watchdog, News on European Medicines Watchdog, stories on European Medicines Watchdog, articles on European Medicines Watchdog, European Medicines Watchdog stories at Wion, European Medicines Watchdog news, European Medicines Watchdog latest news

european medicines-watchdog

European medicines watchdog rejects new Alzheimer's drug